Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (13)

2024

  1. New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 88-96

  2. Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Current situation of the comprehensive approach of heart failure in Spain. The OPTIMISE-IC project

    REC: CardioClinics, Vol. 58, Núm. 4, pp. 289-302

  2. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

2022

  1. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947

  2. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

    Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609

  3. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

    European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46

  4. Prognostic value of a model based on IC-BERG recommendations in ambulatory patients with heart failure

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 76-84

  5. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

    Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184

  6. Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study

    Frontiers in Cardiovascular Medicine, Vol. 9

  7. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

2016

  1. Selección de temas de actualidad en cardiología clínica, cardiología geriátrica e insuficiencia cardiaca y trasplante 2015

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 159-166

2007

  1. Adecuación del tratamiento de los pacientes hipertensos con síndrome metabólico

    Medicina Clinica, Vol. 128, Núm. 17, pp. 647-651